Delivery Order SPE2DB20D2002-SPE2DB25FL78V
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Multaq 400 mg tablets (60-count units) under a firm fixed price contract valued at $4,103.15. The delivery order, issued on July 29, 2025, with an ultimate completion date of July 30, 2025, represents a non-competitive procurement executed through an existing contract vehicle. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Multaq 400 mg tablets in quantities of 60 units. This firm fixed-price delivery order, valued at $5,068.62, is set to be completed by August 11, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The award represents a non-competitive delivery order issued under AmerisourceBergen's existing contract vehicle with DLA, reflecting...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for Multaq 400 mg tablets (60-count units) valued at $1,725.96. This firm fixed price delivery order, issued on August 14, 2025, with completion targeted for August 15, 2025, represents a child contract under AmerisourceBergen's larger pharmaceutical supply agreement with DLA. The award was made through open competition with no set-aside designation, and performance will be fulfilled from the...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Multaq 400 mg tablets (60-count packages) valued at $2,515.53. This firm fixed-price delivery order is set to conclude on August 8, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a non-competitive delivery order issued under an existing contract vehicle, reflecting the company's...
- The Defense Logistics Agency awarded a delivery order valued at $4,560.24 to AmerisourceBergen Drug Corp for the supply of Multaq 400 mg tablets (60 count). This competitive award, issued on July 24, 2025, with an ultimate completion date of July 25, 2025, represents a firm fixed price delivery order with no set-aside designation. The contractor will perform this work from its corporate headquarters in Conshohocken, Pennsylvania, where it maintains operations as a major pharmaceutical...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Multaq 400 mg tablets (60-count units) under a firm fixed-price contract valued at $3,465.96. The order, issued on June 2, 2025, with an ultimate completion date of June 3, 2025, represents a routine pharmaceutical procurement through the DLA's medical supply chain. This non-set-aside competitive award demonstrates the contractor's ongoing role in supporting federal healthcare...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Multaq 400 mg tablets (60-count units) valued at $3,359.77, with an ultimate completion date of September 11, 2025. This competitive award, issued September 10, 2025, utilizes firm fixed-price pricing with no set-aside designation. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary operations as a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Multaq 400 mg tablets (60-count) valued at $7,313.70 under a firm fixed price contract. The award was made on August 21, 2025, with an ultimate completion date of August 22, 2025, and represents a non-set-aside competitive procurement. AmerisourceBergen will perform this delivery order from its corporate office in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for supply of Multaq 400 mg tablets (60-count units) with a ceiling value of $5,600.41. This non-competitive, firm fixed-price delivery order was awarded on April 21, 2025, with an ultimate completion date of April 22, 2025, and represents a child order under AmerisourceBergen's larger contract vehicle with DLA. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, the company's corporate...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Multaq 400 mg tablets (60-count units) with a ceiling value of $1,446.40. This competitively awarded, firm fixed-price delivery order was issued on June 2, 2025, with an ultimate completion date of June 3, 2025. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen's corporate office is located. This award carries no set-aside designation, reflecting the company's...
- SPE2DB20D2002Indefinite Delivery Contract
- SPE2DB20D2002-SPE2DB25FL78VDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Multaq 400 mg tablets (60-count units) with a ceiling value of $4,112.20. This firm fixed-price delivery order, awarded on September 23, 2025, with an ultimate completion date of September 24, 2025, represents a non-competitive, direct fulfillment under an existing contract vehicle. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor with no identified subcontractors on this award. This delivery order is issued under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. This prime contract vehicle supports the comprehensive pharmaceutical supply needs of military healthcare systems globally, encompassing a broad range of brand-name and generic medications, vaccines, and medical supplies across multiple therapeutic domains. The IDC enables flexible ordering by authorized federal customers, including the Defense Health Agency and U.S. Coast Guard, positioning AmerisourceBergen as a critical pharmaceutical distributor within the federal medical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.1k | 9/23/25 |